Canadian Pharmaceuticals & Biotech Big Green Snowflakes

Decibel Cannabis

Market Cap: CA$75.0m

An integrated cannabis company, engages in the cannabis cultivation in Canada.

BioSyent

Market Cap: CA$135.5m

Acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally.

Rubicon Organics

Market Cap: CA$43.0m

Engages in the production, processing, and sale of organic cannabis for the recreational and medical-use markets in Canada and internationally.

Rakovina Therapeutics

Market Cap: CA$9.1m

A biopharmaceutical research company, engages in the research and development of cancer treatments based on novel series of small-molecule DNA-damage response targets.

BriaCell Therapeutics

Market Cap: CA$18.6m

A clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care.

1CM

Market Cap: CA$27.1m

Operates as a multi-jurisdictional cannabis company in Canada.

Medexus Pharmaceuticals

Market Cap: CA$98.5m

Operates as a pharmaceutical company in Canada and the United States.

Innovotech

Market Cap: CA$10.5m

Provides assay kits used in growing microbial biofilms for research purposes in Canada, the United States, and internationally.

Covalon Technologies

Market Cap: CA$62.5m

Engages in the research, development, manufacturing, and marketing of medical products in infection management, advanced wound care, and surgical procedure areas in the United States, Canada, the Middle East, Asia, Latin America, and internationally.

Organigram Global

Market Cap: CA$295.5m

Engages in the production and sale of cannabis and cannabis-derived products in Canada.

High Tide

Market Cap: CA$355.7m

Engages in the cannabis retail business in Canada.

Green Thumb Industries

Market Cap: CA$2.5b

Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.

Auxly Cannabis Group

Market Cap: CA$195.4m

Operates as a consumer packaged goods company in the cannabis products market in Canada.

Bright Minds Biosciences

Market Cap: CA$448.6m

A biotechnology company, develops therapeutics to improve the lives of patients with severe and life-altering diseases in the United States.

Knight Therapeutics

Market Cap: CA$641.8m

Focuses on acquiring, in-licensing, out-licensing, marketing, and commercializing prescription pharmaceutical products in Canada and Latin America.

Cronos Group

Market Cap: CA$1.3b

A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.

NanoSphere Health Sciences

Market Cap: CA$308.3k

A nano-biotechnology company, focuses on providing biologically active compounds in the United States and Canada.

Sweet Earth Holdings

Market Cap: CA$6.6m

Does not have significant operations.

Planet 13 Holdings

Market Cap: CA$100.9m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Aurora Cannabis

Market Cap: CA$377.7m

Engages in the production, distribution, and sale of cannabis and cannabis-derivative products in Canada and internationally.

Satellos Bioscience

Market Cap: CA$112.8m

A biotechnology company, develops medicines to treat degenerative muscle diseases primarily in Canada and Australia.

Christina Lake Cannabis

Market Cap: CA$11.2m

A license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada.

Nextleaf Solutions

Market Cap: CA$12.6m

A cannabis extraction technology company, engages in the manufacture and distribution of cannabinoid vapes, oils, and softgels in Canada.

Cipher Pharmaceuticals

Market Cap: CA$400.8m

Operates as a specialty pharmaceutical company in Canada.

Devonian Health Group

Market Cap: CA$28.7m

Engages in the development of botanical drugs.

Medicenna Therapeutics

Market Cap: CA$88.4m

A clinical-stage immunotherapy company, engages in the development and commercialization of Superkines and empowered Superkines for the treatment of cancer, inflammation, and immune-mediated diseases.

Psyence Group

Market Cap: CA$2.3m

A life science biotechnology company, engages in the research, cultivation, and production of psychedelics and nature-based compounds to treat psychological trauma.

MediPharm Labs

Market Cap: CA$29.5m

Operates as a pharmaceutical company that produces and sells purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally.

Curaleaf Holdings

Market Cap: CA$3.0b

Produces and distributes cannabis products in the United States and internationally.

Medicure

Market Cap: CA$13.8m

A biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States.

XORTX Therapeutics

Market Cap: CA$5.6m

A late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease.

SOL Global Investments

Market Cap: CA$11.5m

A private equity firm specializing in emerging growth.

Delivra Health Brands

Market Cap: CA$6.3m

Through its subsidiaries, provides lifestyle, health, and wellness products to consumers and patients worldwide.

Simply Solventless Concentrates

Market Cap: CA$38.7m

Simply Solventless Concentrates Ltd. cultivates, processes, formulates, manufactures, and sells a portfolio of terpene-rich solventless concentrates for the recreational, medical, and business to business cannabis markets in Canada.

Trulieve Cannabis

Market Cap: CA$1.9b

Operates as a cannabis retailer.

RAMM Pharma

Market Cap: CA$1.2m

Engages in the pharmaceutical and medical product business in Uruguay, Italy, and Poland.